-
Inmazeb: First FDA-Approved Treatment for Ebola
Inmazeb combines three antibodies The U.S. Food and Drug Administration approved Inmazeb (atoltivimab, maftivimab, and odesivimab-ebgn), a mixture…
-
FDA Studying Highly Dangerous Viruses to Inform Development of Vaccines
Ebola at the top of the list for research In order to address the challenges of characterizing the…